RhumbLine Advisers’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $16.5M | Sell |
|
|||||
|
2024
Q4 | $10.5M | Sell |
|
|||||
|
2024
Q3 | $9.23M | Buy |
|
|||||
|
2024
Q2 | $8.57M | Sell |
|
|||||
|
2024
Q1 | $9.49M | Buy |
|
|||||
|
2023
Q4 | $9.66M | Sell |
|
|||||
|
2023
Q3 | $7.15M | Buy |
|
|||||
|
2023
Q2 | $8.51M | Buy |
|
|||||
|
2023
Q1 | $6.95M | Buy |
|
|||||
|
2022
Q4 | $6.77M | Buy |
|
|||||
|
2022
Q3 | $5.68M | Buy |
|
|||||
|
2022
Q2 | $6.41M | Buy |
|
|||||
|
2022
Q1 | $5.38M | Buy |
|
|||||
|
2021
Q4 | $3.99M | Sell |
|
|||||
|
2021
Q3 | $2.88M | Buy |
|
|||||
|
2021
Q2 | $3.02M | Sell |
|
|||||
|
2021
Q1 | $3.19M | Sell |
|
|||||
|
2020
Q4 | $3.23M | Buy |
|
|||||
|
2020
Q3 | $2.29M | Sell |
|
|||||
|
2020
Q2 | $2.59M | Buy |
|
|||||
|
2020
Q1 | $1.26M | Buy |
|
|||||
|
2019
Q4 | $2.35M | Buy |
|
|||||
|
2019
Q3 | $503K | Buy |
|
|||||
|
2019
Q2 | $826K | Buy |
|
|||||
|
2019
Q1 | $735K | Sell |
|
|||||
|
2018
Q4 | $693K | Buy |
|
|||||
|
2018
Q3 | $920K | Sell |
|
|||||
|
2018
Q2 | $912K | Buy |
|
|||||
|
2018
Q1 | $901K | Sell |
|
|||||
|
2017
Q4 | $625K | Sell |
|
|||||
|
2017
Q3 | $689K | Buy |
|
|||||
|
2017
Q2 | $538K | Buy |
|
|||||
|
2017
Q1 | $680K | Buy |
|
|||||
|
2016
Q4 | $610K | Buy |
|
|||||
|
2016
Q3 | $587K | Buy |
|
|||||
|
2016
Q2 | $1.29M | Buy |
|
|||||
|
2016
Q1 | $728K | Buy |
|
|||||
|
2015
Q4 | $1.37M | Buy |
|
|||||
|
2015
Q3 | $767K | Buy |
|
|||||
|
2015
Q2 | $590K | Buy |
|
|||||
|
2015
Q1 | $357K | Buy |
|
|||||
|
2014
Q4 | $215K | Buy |
|
|||||
|
2014
Q3 | $161K | Hold |
|
|||||
|
2014
Q2 | $198K | Buy |
|